LAWSUITS NEWS & LEGAL INFORMATION
P&G Recalls Specific Lots of Vicks Sinex Nasal Spray
Washington, DC: The Procter & Gamble Company has issued a voluntary recall of three lots of its Vicks Sinex nasal spray in three countries: the United States, Germany and the United Kingdom.
The recall was initiated after P&G found the bacteria B. cepacia in a small amount of product made at its plant in Gross Gerau, Germany. There have been no reports of illness. However, the bacteria could cause serious infections for individuals with a compromised immune system, or those with chronic lung conditions, such as cystic fibrosis. B. cepacia poses little medical risk to healthy individuals.
P&G's analysis to date shows this problem is limited to a single batch of raw material mixture involving three lots of product. These three lots were sold only in the United States, Germany and the United Kingdom.
P&G is removing the product in question from store shelves and has informed regulatory authorities in the affected countries. P&G said it found the bacteria B. cepacia in a small amount of product from U.S. lot 9239028831 and is conducting testing on the U.K. and German lots that have been produced from the same batch of raw material mixture.
The affected product in the United States is: Vicks Sinex Vapospray 12-Hour Decongestant Ultra Fine Mist, 15 ml., Nasal Spray. Lot # 9239028831. The lot number is listed on both the outer carton and the bottle.
Published on Nov-20-09
The recall was initiated after P&G found the bacteria B. cepacia in a small amount of product made at its plant in Gross Gerau, Germany. There have been no reports of illness. However, the bacteria could cause serious infections for individuals with a compromised immune system, or those with chronic lung conditions, such as cystic fibrosis. B. cepacia poses little medical risk to healthy individuals.
P&G's analysis to date shows this problem is limited to a single batch of raw material mixture involving three lots of product. These three lots were sold only in the United States, Germany and the United Kingdom.
P&G is removing the product in question from store shelves and has informed regulatory authorities in the affected countries. P&G said it found the bacteria B. cepacia in a small amount of product from U.S. lot 9239028831 and is conducting testing on the U.K. and German lots that have been produced from the same batch of raw material mixture.
The affected product in the United States is: Vicks Sinex Vapospray 12-Hour Decongestant Ultra Fine Mist, 15 ml., Nasal Spray. Lot # 9239028831. The lot number is listed on both the outer carton and the bottle.
Legal Help
If you or a loved one has suffered an adverse health event from using this product, please click the link below and your complaint will be sent to a lawyer who may evaluate your claim at no cost or obligation.Published on Nov-20-09
READ MORE Drugs/Medical Settlements and Legal News